NYSE: BIO

Bio-RAD Laboratories, Inc. (BIO)

Bio-RAD Laboratories, Inc. is a public company that reports to the U.S. Securities and Exchange Commission and trades on NYSE under the ticker BIO. Bright Analyst brings its financial statements, SEC filings, stock performance, news and peer comparisons together in one place, with AI analysis throughout.

Key facts

Ticker symbol
BIO
Exchange
NYSE
SEC CIK
12208
Official filings
SEC EDGAR

Research BIO

  • Profile — Business description, headquarters, subsidiaries and corporate identifiers.
  • Financials — Income statement, balance sheet and cash flow from 10-K and 10-Q filings.
  • SEC Filings — Every 10-K, 10-Q and 8-K, readable inline with AI analysis.
  • Stock Analysis — Price chart, returns, technical indicators and related companies.
  • News — Latest headlines and press coverage.
  • Material Contracts — Material agreements filed as exhibits to SEC reports.
  • Benchmark — Stock performance against the S&P 500, Nasdaq-100 and Dow (through SPY, QQQ and DIA) and economic indicators.
  • Peer Comparison — Side-by-side financial ratios against industry peers.

Frequently asked questions

What is Bio-RAD Laboratories, Inc.'s stock ticker?

Bio-RAD Laboratories, Inc. trades under the ticker symbol BIO on NYSE. Its SEC Central Index Key (CIK) is 12208.

Where can I read Bio-RAD Laboratories, Inc.'s SEC filings?

The BIO SEC Filings page lists the 10-K annual reports, 10-Q quarterly reports and 8-K current reports Bio-RAD Laboratories, Inc. has filed, with AI analysis. The original documents are also on SEC EDGAR.

How can I analyze BIO's financial statements?

The BIO Financials page shows Bio-RAD Laboratories, Inc.'s income statement, balance sheet and cash flow statement, annual and quarterly, taken from its XBRL filings, with an AI analysis of each statement.

How does BIO compare with its peers and the market?

The BIO Peer Comparison page lines Bio-RAD Laboratories, Inc. up against industry peers on valuation, growth and profitability ratios, and the Benchmark page compares its stock with the S&P 500, the Nasdaq-100 and the Dow.

For information only — not investment advice.